NeoHELP-induced tumor control was dependent on the presence of CD4+ and CD8+ T cells, and neoHELP variants encoding the non-mutated, wild-type counterparts of either the CD4 or CD8 neoantigens caused reduced tumor control. Here, CD8A is linked to neoplasm.